Cardiovascular disease (CVD) accounts for more than 17 million deaths per year worldwide. It has been estimated that the influence of lifestyle on CVD mortality amounts to 13.7% for smoking, 13.2% for poor diet, and 12% for inactive lifestyle. These results deeply impact both the healthy status of individuals and their skills in working. The impact of CVD on productivity loss accounts for the 24% in total costs for CVD management. Mediterranean diet (MedD) can positively impact on natural history of CVD. It is characterized by a relatively high consumption of inexpensive and genuine food such as cereals, vegetables, legumes, nuts, fish, fresh fruits, and olive oil as the principal source of fat, low meat consumption and low-tomoderate consumption of milk, dairy products, and wine. Its effects on cardiovascular health are related to the significant improvements in arterial stiffness. Peripheral artery disease, coronary artery disease, and chronic heart failure are all positively influenced by the MedD. Furthermore, MedD lowers the risk of sudden cardiac death due to arrhythmias. The present narrative review aims to analyze the effects of MedD on CVD. J Cardiovasc Med 2017, 18:925-935 
Introduction
Cardiovascular disease (CVD) is the primary global cause of death, responsible for more than 17 million deaths per year. 1, 2 The contribution of unhealthy lifestyle to the development of CVD in high-income and middle-income countries is unquestionable. 3, 4 It has been estimated that the impact on CVD mortality of lifestyle amounts to 13.7% for smoking, 13.2% for poor diet, and 12% for inactive lifestyle. 5, 6 Smoking, poor diet, inactive lifestyle, and excessive alcohol consumption are responsible for almost 40% of all deaths and 80% of chronic diseases in the United States. 5 Improving cardiovascular health is a strategic goal in public health, and improving the average quality of diet is fundamental in achieving such a therapeutic goal. [1] [2] [3] [4] [5] [6] [7] The present narrative review aims to analyze the effects of healthy Mediterranean diet (MedD) on CVD.
'Mediterranean diet' definition and state of the art in the mid-20th century. In this area, after the Second World War nutrition was scarce and characterized by a relatively high consumption of inexpensive and genuine food such as cereals, vegetables, legumes, nuts, fish, fresh fruits, and olive oil as the principal source of fat (Fig. 1) . The consumption of meat was low, whereas the consumption of milk, dairy products and wine was low-moderate ( Fig. 1) . The intake of sophisticated food was almost null. 8 Baseline dietary data showed large differences in saturated fat intake across worldwide cohorts. Intake of saturated fat was low in southern European Mediterranean cohorts and in Japan. 9 Cereals and wine consumption is typical in Italy; bread consumption was high in the Yugoslavian cohorts apart from in Belgrade, with large amounts of vegetables and fish in Dalmatia; olive oil and fruit consumption was high in Greece; fish, rice, and soy products were typical of the Japanese cohorts. 10 It was observed that there were strong and significant associations between saturated fat (as total energy intake proportions) and coronary artery disease (CAD) incidence or mortality. Moreover, there were high inverse relationships between polyunsaturated/saturated fat and monounsaturated/saturated fat ratios on one side and CAD mortality on the other. 11, 12 In the Mediterranean areas, the high monounsaturated/saturated fat ratios reflected the extensive use of olive oil. Although individual saturated fatty acids (FAs), overall fat and dietary cholesterol intake were directly associated with CAD mortality, this was not the case for oleic acid and polyunsaturated FAs. On the other hand, carbohydrate intake was inversely and significantly correlated with CAD rates. These results were compatible with the causal hypothesis that diets high in saturated fat intake -leading to high average levels of serum cholesterol -were responsible for greater CAD incidence and mortality rates across populations.
It was hypothesized that decreasing the consumption of dairy products by half might be associated with a 20% decline in CAD mortality over a 25-year period. A 25% lower consumption of animal foods and a concomitant increase of plant foods by 25% might be associated with a 32% decline in 25-year CAD mortality. 12 A systematic evaluation of eating patterns was carried out over a 25-year follow-up (starting with a testing sample of people aged 45-64 years) in five cohorts (two in Finland, one in the Netherlands, and two in Italy). The general eating habits remained the same throughout the 25 years. Saturated fat decreased by 3% of total energy in Finland and by less than 1% in Italy. 13 New research has confirmed and expanded the concept of MedD and the results of the Seven Country Study. 14, 15 The European Prospective Investigation into Cancer and Nutrition (EPIC) has provided important evidence, based on analyses on large numbers of patients. 16 MedD proved protective on renal function, levels of serum uric acid, weight control, metabolic syndrome, and on developing ischemic stroke. [17] [18] [19] [20] More recently, a study on the MedD has stimulated important comparative procedures between the a-priori and the a-posteriori approach for the definition of dietary patterns. 21 This research period has enabled the concept of MedD to gradually take form and its benefits, regarding low incidence, prevalence, and mortality from CHD, have been expanded to other CVDs, and all-causes mortality including cancer. 22 The characteristics and virtues of the MedD were recently accompanied by a declaration from United Nations Educational, Scientific and Cultural Organization, which classified the MedD as a 'cultural heritage of humanity'. It is however important to stress that there are probably no longer populations homogeneous to the MedD patterns, although within most populations it is certainly possible to identify subgroups of people whose eating habits, casually or deliberately, have enjoyed better health and longevity, by adopting the traditional Seven Countries Study Mediterranean Diet. 2 It has been estimated that 24% of the total costs for CVD in Europe are due to productivity losses. 23 Improving cardiovascular health is a strategic goal in public health. 1, 24, 25 The contribution of unhealthy lifestyle behaviors to the development of CVD in high-income and middle-income countries is unquestionable. 5 Sustainable health policies are needed to promote healthy lifestyle behaviors including not smoking, having a healthy dietary pattern and a normal BMI, abstaining from excessive alcohol use, and maintaining regular physical activity. 3, 6, 23 Smoking cessation is associated with decreased risk for CVD. 4 Regular physical activity is associated with decreased risk for CVD and cardiovascular mortality. 4 A moderate-intensity physical activity for at least 30 min a day five times a week is recommended. 3 Only 27% of adult European citizens meet these activity recommendations. 23 Dietary habits influence CVD risk. 3 In the 2013 WHO Ministerial Conference on Nutrition and NonCommunicable Diseases, it was recognized that 'a healthy diet can contribute to achieving the global targets on NCDs adopted by the Sixty-sixth World Health Assembly, including achieving a 25% relative reduction in premature mortality from NonCommunicable Diseases by 2025'. 26 Core components of a healthy diet include limiting intakes of saturated and trans fats, carbohydrate, alcohol, and sodium and increasing intakes of fruit, vegetables, and dietary fibers. The MedD meets these healthy diet requirements. The cost-effectiveness analysis performed by Abdullah et al. 27 confirms this statement. The analysis estimates that reduction in costs, consequent to an improve management of CVD events, will be of $ 41.9 million in Canada and $1.0 billion in the United States in the 'worst case' scenario represented by a 5% of the population switching to MedD and having a 10% reduction in CVD. 27 
Mediterranean diet and peripheral artery disease
Peripheral artery disease (PAD) is one of the most important manifestations of atherosclerotic disease. 28 The overall prevalence of the disease, assessed in several epidemiological studies, ranges from 3 to 10%, being incremented to 15-20% over the age of 70. 29 The cardiovascular risk factors associated with an increased incidence of PAD are diabetes mellitus and cigarette smoking, followed by arterial hypertension, obesity, and dyslipidemia. In many patients with PAD, these risk factors are simultaneously present, determining the metabolic syndrome. 30 MedD can dramatically improve prognosis, clinical course of PAD, and reduction in negative outcomes (Table 1) .
Mediterranean diet and cardiovascular diseases Mattioli et al. 927 Table 1 The effects of Mediterranean diet on peripheral artery disease: the overview from literature 31 All results were obtained after adjusting for confounding factors. Furthermore, the number-need-to-treat (NNT) was 336 (95% confidential index 269-566) for the MedD plus extra-virgin olive oil group and 448 (95% confidential index 316-1536) for the MedD plus nuts group. Although these numbers are far from those of well established pharmacological treatments (i.e. NNT for PAD primary prevention with statins: from 24 to 42 32 ; NNT for PAD primary prevention with ACE-inhibitors: 7 (95% confidential index 5-12) 33 ), they suggest an important role of eating habits on PAD progression. A further analysis revealed a number of expected prevented PAD cases of 10 out of 1000 patients. 34 Ciccarone et al. 35 showed the protective role of the MedD in counteracting PAD development in patients with type 2 diabetes mellitus. They observed that the higher the MedD score -representing greater adherence to MedD -the lower the risk of PAD. Although diabetes duration and hypertensive condition can negatively impact PAD occurrence, a high MedD score is associated with a decrease progression of the disease. Patients in the lowest score tertile showed a 2.63 (diabetes duration <10 years) and 3.9-fold (diabetes duration >10 years) higher risk of PAD progression as compared with their higher counterparts. 35 Such differences dramatically increased when considering hypertensive condition: hypertensive individuals who poorly followed MedD displayed a 5.9-fold higher risk of PAD than those adhering to MedD. 35 The EPIC-NL cohort study supported the previous findings. 36 The Authors prospectively followed up 40 011 men and women aged 20-70 years. They were enrolled between 1993 and 1997 and followed for 10-15 years (mean 11.8 years). 36 The study was design for investigating the influence of MedD on cardiovascular outcomes occurrence. By splitting results, the authors observed a 26% [hazard ratio: 0.74 (95% confidential index 0.45-1.21), after correction for confounding factors] reduction in PAD occurrence in patients highly adherent to MedD, as assessed by means of the modified Mediterranean diet score. 36 The reasons for such improvements in the overall cardiovascular risk burden of individuals prone to or suffering from PAD are not fully understood. Klonizakis et al. 37 showed that vascular function may benefit from MedD. The lower limb vascular endothelial cutaneous vascular conductance improved in patients who had undergone MedD even at 1-year follow-up. 37 Although the study was not set for PAD patients -the authors enrolled 20 healthy individuals -it provides insights on possible mechanisms explaining the positive effects of MedD in such patients.
The reasons behind the improvement of disease and the prevention of PAD in patients following MedD regimen can be related to the positive effect on arterial walls. 38 The Amsterdam Growth and Health Longitudinal Study compared longitudinal levels of adherence with MedD, during adolescence and adulthood (two to eight repeated measures obtained between the ages of 13 and 36 years) between individuals, with different levels of arterial stiffness in adulthood. 39 The study population included 373 (196 women) apparently healthy adults who underwent carotid, brachial, and femoral arteries ultrasound evaluations at 36 years of age. After adjustments for confounders, individuals with stiffer carotid arteries had lower adherence scores and were less likely to have adhered to this dietary pattern during the preceding 24 years compared with those with less stiff arteries. Therefore, MedD may prevent arterial stiffness in adulthood, and consequently the development of PAD. 39 MedD can also influence the peripheral atherosclerotic burden. Gardener et al. 40 outlined the positive effect of MedD on carotid plaque thickness and median plaque area progression: the 1374 patients enrolled in the Northern Manhattan Study showed that the increase in 1 point of MedD score was able to significantly reduce the 75th percentile of plaque thickness (À0.049 mm, P ¼ 0.03, after adjusting for confounding factors) and the median of plaque area (À0.371 mm 2 , P ¼ 0.03). Mediterranean diet in chronic coronary artery disease patients CAD is the most common cause of death in developed countries, responsible for about one out of five deaths. Chronic stable angina (CSA) is the first presentation of CAD in about 50% of patients, affecting about 17 million people in the United States. 43 Nutrition plays an increasingly significant role for secondary prevention of cardiovascular events in CSA. [44] [45] [46] [47] MedD can further improve the outcomes of these patients ( Table 2 ). The PREDIMED study 22 on primary prevention of adverse outcomes revealed a significant reduction in the primary composite endpoint of the study [acute myocardial infarction (MI), stroke, or death from cardiovascular causes]: the use of MedD plus olive oil (hazard ratio: 0.70, 95% confidential index 0.53-0.91, P ¼ 0.009) and MedD plus nuts (hazard ratio: 0.70, 95% confidential index 0.53-0.94, P ¼ 0.02) both decreased the incidence of the composite endpoint of 30%. Nevertheless, when splitting the single endpoints, they found that previous results were triggered by the significant reduction in stroke occurrence rather than acute MI of death from cardiovascular causes. Similar results came from the analyses of the Northern Manhattan Study 48 : higher adherence to MedD did not significantly reduce the occurrence of MI (hazard ratio: 0.65, 95% confidential index 0.38-1.12, P ¼ 0.27). Nevertheless, the EPIC-NL cohort study 36 in apparently healthy individuals outlined the significant reduction in the occurrence of MI after adjusting for confounders in patients showing higher adherence to MedD (hazard ratio: 0.86, 95% confidential index 0.79-0.93).
The cardiovascular Spanish section of the EPIC study -a prospective European study involving healthy individuals -pointed out a further 40% reduction in the risk of CAD occurrence in the patients highly adherent to MedD (hazard ratio: 0.60, 95% confidential index 0.47-0.77, P < 0.001), even after the adjustment for confounders. 49, 50 The Lyon Diet Heart Study provided information about the role of MedD in the secondary prevention of adverse outcomes after acute MI. 51, 52 This was a randomized, single-blind secondary prevention trial in patients analyzing the incidence of three composite outcomes: MI plus cardiovascular death (composite outcome 1); MI plus cardiovascular death plus major secondary events (unstable angina occurrence, overt heart failure, stroke, or pulmonary or peripheral embolism) (composite outcome 2); the preceding plus minor events requiring hospital admission, including recurrent stable angina, postangioplasty restenosis, surgical or medical myocardial revascularization, and thrombophlebitis (composite outcome 3). MedD was able to significantly reduce the occurrence of all-cause and cardiovascular death (P < 0.05). All the three composite outcomes were significantly reduced (P ¼ 0.0001 for composite outcome 1 and composite outcome 2 and P ¼ 0.0002 according to composite outcome 3). At multivariate proportional-hazards analyses, MedD was able to reduce the occurrence of composite outcome 1 of 72% [conditional risk ratios (CRRs) 0.28, 0.15-0.53, P < 0.05], composite outcome 2 of 67% (CRR 0.33, 0.21-0.52, P < 0.05), and composite outcome 3 of 47% (CCR 0.53, 0.38-0.74, P < 0.05). 51 A subanalysis 53 of the GISSI-Prevenzione study involving patients surviving recent (3 months or less) MI Mediterranean diet and cardiovascular diseases Mattioli et al. 929 Table 2 The effects of Mediterranean diet on chronic coronary artery disease: the overview from literature pointed out a 15% (95% confidential index 12-18%) reduction in the occurrence of mortality each unit increase in the MedD score. The authors calculated a 14% reduction in the overall risk of mortality after 6.5-year follow-up. 53 Although this subanalysis did not reveal the incidence of further coronary events, data on mortality are fundamental to consider the overall impact of MedD on health.
The prospective analysis from Iestra et al. 54 outlined the reduction in mortality risk (hazard ratio: 0.75; 95% confidential index 0.57-0.97) in patients following MedD and recently suffering from MI. 54 The hypotheses accounting for the positive effects of MedD on cardiovascular outcomes of patients suffering from CAD are different, but not conclusive. A subanalysis from PREDIMED study pointed out the reduction in CD40 expression on monocytes surface (34%, P ¼ 0.03), and a further decrease in C-reactive protein and IL-6 in both MedD groups (plus olive oil and plus nuts). 55 Accordingly, the expression of adhesion molecules such as soluble intracellular Cell Adhesion Molecule and Pselectin was significantly reduced in both groups as compared with controls (P ¼ 0.04). 55 All of these molecular changes suggest a protection of atherosclerotic plaques from instability and/or negative progression related to the adherence to MedD, which was persistent even at 12-month follow-up. The 5-year follow-up of this group of patients confirmed the statistical significant reduction in inflammatory markers 56 : IL-6 and IL-8, monocyte chemotactic protein-1, TNF-a, adhesion molecules were significantly reduced following MedD treatment, acting as a possible mechanism for cardiovascular risk prevention. Therefore, as confirmed by literature, MedD may play a crucial role in primary and secondary prevention of CADs. 57 Mediterranean diet in patients with chronic heart failure Despite significant advances in pharmacological and nonpharmacological therapy, heart failure continues to have high morbidity and mortality and its prevalence is increasing in most regions of the world. 58, 59 There is consequently an evident need for novel therapeutic approaches. Nutritional interventions appear to be particularly attractive because they could work additively with established therapies without exerting negative hemodynamic effects.
Healthy dietary patterns in general, including some components of the MedD, have been associated with lower incidence of heart failure in some observational studies (Table 3) . [60] [61] [62] Recently, Tektonidis et al. 63 in a prospective study that included 37 308 men from Sweden free from CVD at baseline, firstly demonstrated that high adherence to MedD (assessed by a MedD score) was Table 3 The effects of Mediterranean diet on chronic heart failure: the overview from literature associated with a 31% [relative risk (RR): 0.69, 95% confidential index 0.57-0.83; P for trend <0.001] reduction in risk of heart failure development over a median follow-up time of 10.9 years. Moreover, mortality related to heart failure was significantly reduced in patients highly adherent to MedD (RR: 0.55, 95% confidential index 0.31-0.98; P for trend ¼ 0.007), after adjusting for confounding factors. 63 Data from 'PREDIMED' did not show reduction in heart failure occurrence in the population following MedD combined with extra-virgin oil or nuts as compared with controls. 64 Despite the strict adherence to the dietetic regimens, there was a similar incidence of heart failure among the three groups at 4.8-year median follow-up. Heart failure was a secondary outcome of the PRE-DIMED study and, probably, was underpowered for the final analysis. Authors suggested a further controlled trial designed ad hoc for this purpose. Despite this lack of difference among groups, Fitó et al. 65 observed a significant reduction in plasma N-terminal pro-brain natriuretic peptide in MedD groups as compared with controls, whereas no variation was observed in urinary albumin or albumin/creatinine ratio.
The EPIC-Potsdam substudy confirmed the PRE-DIMED results 66 : among the 9225 men and 14 783 women enrolled in the study, there was no relationship between heart failure occurrence and adherence to MedD. Although the gross analysis revealed a significant reduction in heart failure occurrence, the multivariate regression analysis did not confirm the results (highest adherence group: hazard ratio: 0.66, 95% confidential index 0.41-1.08, P for trend 0.10). 66 Further analysis should be considered in the adoption of MedD in the setting of strategies for primary prevention of heart failure.
An interesting point of view about this matter comes from the analysis of the Multi-Ethnic Study of Atherosclerosis study. 67 The authors applied the MedD score for the evaluation of these patients whose cardiac function and morphology were also combined for the final evaluation. The higher the MedD score the higher the left ventricle (LV) mass and volume, as well as stroke volume and LV ejection fraction. This cross-sectional association revealed the skills of MedD to enhance the structure and the function of the LV in apparently healthy individuals.
Different results come from the analysis of secondary prevention studies. A subanalysis from the Women's Health Initiative study involved about 3215 participants who experienced hospitalization for heart failure. 68 These women were followed up for a median time of 4.6 years, and their daily dietary patterns were also periodically evaluated. Patients showing higher MedD adherence showed a trend for reduced mortality for heart failure (hazard ratio: 0.85, 95% confidential index 0.70-1.02, P ¼ 0.08) after adjusting for several confounding factors. 68 A good adherence to MedD after acute coronary syndrome (ACS) was significantly associated with reduced incidence of LV dysfunction during hospitalization, whereas higher MedD score showed a trend toward reduced negative LV remodeling within 3 months after the acute event. 69 Significantly, Chrysohoou et al. 70 observed that greater adherence to MedD was slightly associated with better LV filling pressure and better biventricular systolic function in chronic heart failure patients with LV ejection fraction less than 40%. In particular, after adjusting for potential confounding factors (e.g. age, sex, physical inactivity, smoking habits, obesity, history of hypertension, hypercholesterolemia and diabetes mellitus, ejection fraction, and years of heart failure), log E wave/A wave ratio was inversely associated with the MedD score. 70 Furthermore, aliment-specific analysis revealed the potential beneficial effect of vegetables, fish, and olive oil on LV and right ventricular systolic and diastolic indices, suggesting a further nonpharmacological therapeutic strategy in these patients. 70 In conclusion, even though evidence is not conclusive, MedD may positively impact on reverse remodeling in heart failure patients or in patients likely to develop heart failure.
Mediterranean diet effects on arrhythmias and sudden cardiac death
The effects of MedD on arrhythmias prevention and/or sudden cardiac death (SCD) are poorly established (Table 4) . 71 The GISSI-Prevenzione Investigators demonstrated that early administration of v-3 poly-unsatured fatty acids (PUFA) supplementation (a well established component of MedD) in patients recently suffering from ACS can reduce the occurrence of SCD. 72 The authors suggested a possible antiarrhythmic role of v-3 PUFA on heart as the key role for SCD prevention. The Women's Health Initiative substudy involved 93 122 postmenopausal women who were evaluated for the MedD and, in parallel, for the occurrence of SCD. 73 The research found a total of 237 SCD. The statistical analyses and the corresponding adjustment for confounding factors did not outline the superiority of higher adherence to MedD in prevention of SCD. Nevertheless, women in the highest quintile showed a not significant 36% reduction (highest to lowest quintile hazard ratio: 0.64, 95% confidential index 0.43-0.94, P ¼ 0.21) in SCD reduction as compared with those poorly adherent to MedD. 73 The Isfahan Cohort Study considered a composite endpoint of fatal MI, fatal stroke (i.e. death from cerebrovascular disease) and SCD; it demonstrated that MedD was effectively able to strongly reduce the occurrence of the primary endpoint (hazard ratio: 0.42, 95% confidential index 0.19-0.96, P for trend ¼ 0.02 after adjusting for confounding factors) more than other dietary patterns (i.e. Western diet, animal fat diet, and fast food diet). 74 Data on the relationship between MedD and atrial fibrillation occurrence/recurrences are controversial (Table 4) . The changes in nutritional habits might reduce the occurrence of arrhythmias. [75] [76] [77] According to MedD, a post-hoc analysis of the PREDIMED study revealed a 38% (hazard ratio: 0.62; 95% confidential index 0.45-0.85 vs. control group) reduction in atrial fibrillation occurrence when adopting MedD plus olive oil. These data were obtained after adjusting for confounding factors. 77 Mattioli et al. 76 confirmed the lower incidence of atrial fibrillation in patients following MedD as compared with controls. The interesting result of their research was related to the higher probability of sinus rhythm conversion in patients highly adherent to MedD. They observed a 90% (odds ratio 1.90, 95% confidential index 1.58-2.81, P ¼ 0.001) probability of fast rhythm conversion in patients declaring high MedD score. 76 An interesting insight from Mattioli et al. 76 was related to a possible role of antioxidant properties of MedD on atrial fibrillation expression. Pastori et al. 78, 79 confirmed such pathogenetic hypothesis. This group observed that higher adherent atrial fibrillation patients showed reduced levels of soluble NADPH oxidase 2-derived peptide and F2-isoprostanes, 78 and increased levels of glutathione peroxidase 3. 79 These results confirmed the antioxidant properties of MedD in atrial fibrillation, thus suggesting positive effects for the conversion or reduction of its occurrence/recurrence. Furthermore, MedD can prevent major cardiovascular events related to atrial fibrillation. 78, 80 Beyond antioxidant properties, the demonstration of stable time-intherapeutic range for warfarin-treated patients 80, 81 as well as the reduction in thromboxane A2 production (i.e. Table 4 The effects of Mediterranean diet on arrhythmias and sudden cardiac death: the overview from literature MedD significantly reduced the risk of metabolic syndrome and protected against risk factors such as waist circumference, lipids, glucose, and blood pressure in primary prevention 20 MedD provided a more robust reduction in cardiovascular disease risk factors and inflammatory markers 55, 56 Nutrition plays an increasingly significant role for secondary prevention of CV events in CSA 47 MedD have been associated with lower incidence of HF in some observational studies [60] [61] [62] Potential beneficial mechanisms related to high intake of fruit and vegetables, strongly present in MedD Antioxidant properties of fruit and vegetables 84 Well known health benefits of high flavonol intake 85 Potential increase in nitric oxide species 86 Concomitant weight loss associated with diets high in fruits and vegetables.
Reduction of blood pressure 87 Reduction of inflammatory markers CSA, chronic stable angina; CV, cardiovascular; HF, heart failure; MedD, Mediterranean diet.
reduced tendency to platelets to aggregate) 82 accounts for the reduced rate of atrial fibrillation-related adverse events.
Although confirmatory, structured, randomized trials should be adopted for these issues, the scientific background seems to favor the MedD in possible, positive influence on outcomes of SCD and/or atrial fibrillation patients.
Conclusion
The MedD is a reliable weapon against CVD progression. It positively affects endothelial function, arterial stiffness, and cardiac remodeling ( Fig. 1 and Table 5 ). [83] [84] [85] [86] [87] The consequence is a reduction in the occurrence of PADs, improvements in the outcomes of CADs and heart failure ( Fig. 1 and Table 5 ). [83] [84] [85] [86] [87] Therefore, the adoption of MedD can reduce the CVD manifestations and consequences, promoting healthy lifestyle and best management of body care.
